EU Pharmaceutical Law Forum 2024
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels
Wednesday 22 May 2024
Stay at the Forefront of Key Developments in Real World Consequences of Regulatory Policy
Leave with Practical Legal Guidance from the Highest Flyers at the EU Commission & EMA, Including Specialist Expertise from a European Parliament Rapporteur
Benchmark Your Regulatory Legal Progress With Real World Insights On Key Pharmaceutical Legal Issues:
Real World Consequences of Regulatory Policy
- Exclusive Rapporteur’s analysis into the EU pharmaceutical legislation revision
- Impact of revisions on Europe's competitiveness and investment landscape
- Developments to incentive schemes and the regulatory challenges
How can Pharmaceutical Companies Protect their Rights?
- Analysis of business risks posed by Leadiant Case
- Enforcement of market exclusivity: What measures can originators take?
- Price transparency scrutiny: Recent decisions and legal concerns
Latest Advances in Regulatory Frameworks
- Frameworks, guidance and risks of decentralized clinical trials
- Developments for the AI Act and EMA approach to AI
- Managing the conflict of IVDR with the EU CTR for companion diagnostics
Introducing the Regulatory Frameworks Speaker Line Up: